Factor XIa Inhibitors as a Novel Anticoagulation Target: Recent Clinical Research Advances

Background: While current clinically administered anticoagulant medications have demonstrated effectiveness, they have also precipitated significant risks: severe bleeding complications including, but not limited to, gastrointestinal hemorrhaging and intracranial and other life-threatening major ble...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Yunqing, Hu, Yu, Tang, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10300994/
https://www.ncbi.nlm.nih.gov/pubmed/37375813
http://dx.doi.org/10.3390/ph16060866

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10300994/
https://www.ncbi.nlm.nih.gov/pubmed/37375813
http://dx.doi.org/10.3390/ph16060866

Ejemplares similares